MarketInOut Stock Screener Log In | Sign Up

Sun Pharma Advanced Research Company Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:50
Sun Pharma Advanced Research Company Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization55,737 mln
Float87.91 mln
Earnings Date11/02/2026

EPS

48.81
Exceptional

P / E

3.74
Deeply undervalued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

21.49
Highly suspicious

Relative Strength

67 / 100
Outperforming

Debt / Equity

0.42
Low leverage

Business Description

Sun Pharma Advanced Research Company is an India-based company focused on discovering and developing new medicines for cancer and immune system disorders. Founded in 2006 and headquartered in Mumbai, it operates both locally and across global markets. Several of its drug candidates are currently being tested in clinical trials, targeting conditions such as leukemia, psoriasis, and skin diseases, while others are at earlier stages of research addressing hair loss and certain cancers.

Key Fundamentals

EPS48.81
P/E3.74
ROE612
RPS58.82
ROIC144
ROA168
Interest Cover44.56
EBITDA, mln16,300
EV / EBITDA4.50
EV / EBIT4.53
Revenue, mln19,094
EV / Revenue3.84

Quote Details

Last 182.50
Change 3.5 (1.96%)
Open 178.00
Volume 45,566
Turnover 8,315,795
Average Volume 86,399

Financial Ratios

Pre-Tax Profit Margin83
Current Ratio2.47
Price / Book4.78
Price / Tangible Book5.05
Debt / Equity0.42
Price / Sales3.35

Financial Strength

Altman Z-Score8.35
Piotroski F-Score 7 / 9
Beneish M-Score21.49
Price to Graham Number0.96

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.03% 69 / 100   
1 Month -10.54% 35 / 100   
2 Months -19.82% 21 / 100   
6 Months 32.15% 87 / 100   
1 Year 38.47% 89 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog